Exane Derivatives’s Avadel Pharmaceuticals AVDL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $81 | Hold |
33
| – | – | ﹤0.01% | 724 |
|
|
2022
Q1 | $225 | Sell |
33
-207
| -86% | -$1.41K | ﹤0.01% | 950 |
|
|
2021
Q4 | $1.94K | Sell |
240
-7,582
| -97% | -$61.3K | ﹤0.01% | 655 |
|
|
2021
Q3 | $76.7K | Sell |
7,822
-1,078
| -12% | -$10.6K | 0.02% | 555 |
|
|
2021
Q2 | $60.5K | Hold |
8,900
| – | – | 0.01% | 611 |
|
|
2021
Q1 | $80.5K | Hold |
8,900
| – | – | 0.02% | 442 |
|
|
2020
Q4 | $59.4K | Hold |
8,900
| – | – | 0.02% | 435 |
|
|
2020
Q3 | $44.9K | Hold |
8,900
| – | – | 0.01% | 361 |
|
|
2020
Q2 | $71.9K | Buy |
+8,900
| New | +$71.9K | 0.02% | 309 |
|